BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gavriilidis E, Antoniadou C, Chrysanthopoulou A, Ntinopoulou M, Smyrlis A, Fotiadou I, Zioga N, Kogias D, Natsi AM, Pelekoudas C, Satiridou E, Bakola SA, Papagoras C, Mitroulis I, Peichamperis P, Mikroulis D, Papadopoulos V, Skendros P, Ritis K. Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure. Clin Immunol 2022;:109016. [PMID: 35447311 DOI: 10.1016/j.clim.2022.109016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Chrysanthopoulou A, Antoniadou C, Natsi AM, Gavriilidis E, Papadopoulos V, Xingi E, Didaskalou S, Mikroulis D, Tsironidou V, Kambas K, Koffa M, Skendros P, Ritis K. Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling. Clin Immunol 2023;247:109240. [PMID: 36693535 DOI: 10.1016/j.clim.2023.109240] [Reference Citation Analysis]
2 Pu L, Li Z, Huang F, Li L, Ma Y, Ma M, Hu S, Wu Z. Efficient synthesis of novel colchicine-magnolol hybrids and evaluation of their inhibitory activity on key proteases of 2019-nCoV replication and acute lung injury. Natural Product Research 2022. [DOI: 10.1080/14786419.2022.2138870] [Reference Citation Analysis]
3 Masso-Silva JA, Sakoulas G, Olay J, Groysberg V, Geriak M, Nizet V, Crotty Alexander LE, Meier A. Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin. Front Immunol 2022;13:993720. [PMID: 36341409 DOI: 10.3389/fimmu.2022.993720] [Reference Citation Analysis]
4 Atal S, Sampath A, Banerjee A, Jhaj R. Baricitinib in the Treatment of COVID-19. COVID-19 Drug Development - Recent Advances, New Perspectives, and Applications [Working Title] 2022. [DOI: 10.5772/intechopen.107269] [Reference Citation Analysis]
5 Ngo ATP, Gollomp K. Building a better NET : Neutrophil extracellular trap targeted therapeutics in the treatment of infectious and inflammatory disorders. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12808] [Reference Citation Analysis]
6 Zhang R, Sun C, Han Y, Huang L, Sheng H, Wang J, Zhang Y, Lai J, Yuan J, Chen X, Jiang C, Wu F, Wang J, Fan X, Wang J. Neutrophil autophagy and NETosis in COVID-19: perspectives. Autophagy 2022;:1-10. [PMID: 35951555 DOI: 10.1080/15548627.2022.2099206] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wienkamp A, Erpenbeck L, Rossaint J. Platelets in the NETworks interweaving inflammation and thrombosis. Front Immunol 2022;13:953129. [DOI: 10.3389/fimmu.2022.953129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Taylor E. Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection. Clinical Science 2022;136:1047-52. [DOI: 10.1042/cs20220039] [Reference Citation Analysis]
9 Chowdary P. COVID-19 coagulopathy - what should we treat? Exp Physiol 2022. [PMID: 35733235 DOI: 10.1113/EP089404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]